tradingkey.logo
tradingkey.logo

Bruker falls after trimming annual forecast

ReutersAug 4, 2025 2:18 PM

Life science and clinical research company Bruker Corp BRKR.O shares down about 5.9% at $35.75 in early trading

Lowers FY 2025 adj. EPS between $1.95 - $2.05 from prior expectations of $2.40 - $2.48

Trims FY 2025 revenue outlook to $3.43 bln - $3.50 bln from previous target of $3.48 bln - $3.44 bln

Expanded cost savings initiative expects to cut annual costs by $100-$120 mln in FY 2026

Misses Q2 revenue and adj. profit estimates, hurt by challenging demand conditions in the U.S. academic market

"Tariffs and stiff currency headwind could not be compensated by mitigating price, supply chain and cost actions in Q2." - CEO Laukien

Stocks down 35.19% YTD

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Tradingkey

Recommended Articles

Tradingkey
KeyAI